Enzyme Replacement Therapy
Links shared publicly online about this topic
Enzyme Replacement Therapy Improves Outcomes In Fabry's Disease
medicalnewstoday.com — “A five-year study has shown that enzyme replacement therapy improves clinical outcome, including reducing pain and improving quality of life, in patients with Fabry's Disease. This is the co” View full resource at medicalnewstoday.com
Most Recently Shared on December 2, 2009 at 11:11 am By:
Enzyme Replacement Therapy Improves Outcomes In Fabry's Disease: A five-year study has shown that enzyme replacemen... http://bit.ly/8JJ67c
Inventive Approach May Improve Enzyme Replacement Therapy For Fabry Disease
medicalnewstoday.com — “A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that oft” View full resource at medicalnewstoday.com
Most Recently Shared on October 24, 2009 at 11:08 am By:
MedicalNewsToday: Inventive Approach May Improve Enzyme Replacement Therapy For Fabry Disease http://bit.ly/Cn7FY Full http://bit.ly/45ozpt
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data : The Lancet
thelancet.com — “Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. By - Dr A Mehta FRCP, Prof M Beck MD, P Elliott FRCP, Prof R Giugliani MD, Prof A Lin...” View full resource at thelancet.com
Most Recently Shared on December 2, 2009 at 7:11 pm By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Enzyme replacement with algasidase alpha in patients with Fabry's disease - improved outcomes - http://bit.ly/6MjnmX
ENB-0040, A Bone Targeted Enzyme Replacement Therapy, Shows Promise In Children With Hypophosphatasia
medicalnewstoday.com — “Enobia Pharma announced positive interim data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After” View full resource at medicalnewstoday.com
Most Recently Shared on June 22, 2010 at 2:06 pm By:
MNT Bones/Orthopedic Health News
ENB-0040, A Bone Targeted Enzyme Replacement Therapy, Shows Promise In Children With Hypophosphatasia http://mnt.to/3Fb3 #bones #orthopedics
Enobia Provides Update On Progress With ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia
medicalnewstoday.com — “Enobia Pharma provided an update on key developments in its comprehensive effort to develop ENB-0040 (asfotase alfa), an experimental bone-targeted enzyme replacement therapy, for the treatment of” View full resource at medicalnewstoday.com
Most Recently Shared on September 9, 2010 at 3:00 pm By:
MNT Bones/Orthopedic Health News
Enobia Provides Update On Progress With ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia http://mnt.to/3Jvh
Enobia Announces Successful Completion Of Phase II Juvenile Study Of ENB-0040, A Bone Targeted Enzyme Replacement Therapy
medicalnewstoday.com — “Enobia Pharma Inc., announced that it has successfully completed a Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in juveniles with hypophosphatasia (HPP” View full resource at medicalnewstoday.com
Most Recently Shared on January 11, 2011 at 3:05 pm By:
MNT Bones/Orthopedic Health News
Enobia Announces Successful Completion Of Phase II Juvenile Study Of ENB-0040, A Bone Targeted Enzyme Replacement Therapy http://mnt.to/3PR3
Enobia Expands Clinical Program For ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia
medicalnewstoday.com — “Enobia Pharma announced the initiation of a Phase 2 clinical study of ENB-0040, a bone-targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six” View full resource at medicalnewstoday.com
Most Recently Shared on November 4, 2009 at 2:30 pm By:
#HEALTH Enobia Expands Clinical Program For ENB0040, A BoneTargeted Enzyme Replacement Therapy For Hypophosphatasia http://ow.ly/15ZnaD
Enobia Announces Completion Of Enrollment In Third Phase II Hypophosphatasia Study Of ENB-0040, A Bone Targeted Enzyme Replacement Therapy
medicalnewstoday.com — “Enobia Pharma Inc., announced that it has successfully completed enrollment in its Phase II study of ENB-0040, a bone targeted enzyme replacement therapy being investigated in adolescents and adul” View full resource at medicalnewstoday.com
Most Recently Shared on February 25, 2011 at 6:05 pm By:
MNT Bones/Orthopedic Health News
Enobia Announces Completion Of Enrollment In Third Phase II Hypophosphatasia Study Of ENB-0040, A Bone Targeted Enzyme... http://mnt.to/3RBV
Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease
news-medical.net — “Shire plc, the global specialty biopharmaceutical company, announces that Health Canada has approved VPRIV (velaglucerase alfa), an enzyme replacement therapy (ERT) for long-term use in pediatric and adult type 1 Gaucher disease.” View full resource at news-medical.net
Most Recently Shared on December 1, 2010 at 12:14 pm By:
Health Canada approves VPRIV enzyme replacement therapy for type 1 Gaucher disease: Shire plc, the global specia... http://bit.ly/eXIaXq
Synageva BioPharma seeks FDA orphan drug designation for SBC-102 enzyme replacement therapy
news-medical.net — “Synageva BioPharma Corp., a privately held biopharmaceutical company, today announced its filing with the U.S. Food and Drug Administration (FDA) requesting orphan drug designation for its program, SBC-102. This program is an enzyme replacement therapy in preclinical development to treat lysosomal acid lipase (LAL) deficiency, also known as Wolman disease or cholesteryl ester storage disease (CESD), a condition for which there is currently no effective treatment.” View full resource at news-medical.net
Most Recently Shared on May 4, 2010 at 1:36 pm By:
Synageva BioPharma seeks FDA orphan drug designation for SBC-102 enzyme replacement therapy: Synageva BioPharma Co... http://bit.ly/c0taPL
Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Replacement Therapy - Drugs.com MedNews
drugs.com — “Company Highlights Clinical Progress, Advances toward Commercial Preparedness at J.P. Morgan Healthcare Conference SAN FRANCISCO, Enobia Pharma Inc., today anno” View full resource at drugs.com
Most Recently Shared on January 11, 2011 at 7:13 pm By:
Drugs and Devices OW OW Health
Enobia Announces Successful Completion of Phase II Juvenile Study of ENB-0040, a Bone Targeted Enzyme Repl... http://bit.ly/ggrK1d #drug
Enzyme Replacement May Help in Fabry Disease
palmbeachpost.com — “New research suggests that enzyme replacement therapy can make a major difference in the lives of people with Fabry disease, a rare illness that affects the kidneys, heart and brain.” View full resource at palmbeachpost.com
Most Recently Shared on December 2, 2009 at 7:32 pm By:
low sodium foods Health Business
Enzyme Replacement May Help in Fabry Disease - Palm Beach Post http://bit.ly/6zeG70
Enzyme Replacement May Help in Fabry Disease - Drugs.com MedNews
drugs.com — “New research suggests that enzyme replacement therapy can make a major difference in the lives of people with Fabry disease, a rare illness that affects the kid” View full resource at drugs.com
Most Recently Shared on December 3, 2009 at 12:04 am By:
Enzyme Replacement May Help in Fabry Disease - http://bit.ly/5KkLWt
Therapies: Enzyme Therapy
library.thinkquest.org — “Therapies: Enzyme Therapy” View full resource at library.thinkquest.org
Most Recently Shared on October 26, 2010 at 2:00 am By:
In Oct. of 2009, Sue became a Certified Natural Health Professional, and
in 2011 became Certified as a Digestive Health Specialist through the
Loomis Institute of Enzyme Nutrition, and is also a member of the
American Holistic Nurses Association. Sue has a private practice in
Green Bay, WI., but has the priviledge of having and serving clients in
areas of Nova Scotia, Boston, Minnesota, West Virginia, and the Fox
Valley area of WI. She maintains her current WI Nursing Licensure. We welcome you to
contact us about cancer-fighting supplements used in Sue's treatment.
" /> Suzan Macco RN, CNHP, Loomis Digestive Health Specialist Nurse and Active Health Library
For every chemical reaction that occurs in the body, enzymes provide the stimulus. http://bit.ly/cNa4k0
Enzyme Replacement a Promising Treatment for Children With Hypophosphatasia - QualityPoint Technologies
qualitypointtech.net — “Enzyme replacement therapy improves radiographic appearance of bone, as well as mobility, muscle strength, endurance, and agility, in children with hypophosphatasia. Medscape Medical News” View full resource at qualitypointtech.net
Most Recently Shared on October 18, 2010 at 8:17 pm By:
Enzyme Replacement a Promising Treatment for Children With Hypophosphatasia: Enzyme replacement therapy improves r... http://bit.ly/ciVryb
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
MNT Biology News
The latest biology news published daily. Articles from research centers, universities and prestigious journals.
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
-
M Auron MD
Internist and Pediatrician. Hospitalist.
Advertisement
